trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'breast', 'astrazenecaus', 'astrazeneca']
trastuzumab deruxtecan cuts risk of disease progression or death by 50% for patients with her2-low metastatic breast cancer #asco22 via 
Health is a state of mind. Practicing #yoga. Fan of @onepeloton, @Eagles @SJUHawks, and all things #NOLA.